| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Jan 25 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 144,928 | 0.00 | 594,252 |
| 24 Jan 25 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.94 | 512,370 | 994.00 k | 512,370 |
| 21 Aug 24 | ALLO Allogene Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 2.785 | 28,310 | 78.84 k | 449,324 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 41,800 | 0.00 | 477,634 |
| 25 Jan 24 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.2 | 147,778 | 472.89 k | 147,778 |
| 14 Aug 23 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 326,876 | 0.00 | 435,834 |
| 14 Aug 23 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 108,958 | 0.00 | 108,958 |
| 14 Aug 23 | ALLO Allogene Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.13 | 960,854 | 3.97 mm | 960,854 |
